ICAD
ICAD Inc
Price:  
1.97 
USD
Volume:  
342,029.00
United States | Health Care Technology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ICAD Relative Valuation

-260.6%
Upside

As of 2024-12-12, the Relative Valuation of ICAD Inc (ICAD) is (3.16) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.97 USD, the upside of ICAD Inc based on Relative Valuation is -260.6%.

The range of the Relative Valuation is (1.87) - (4.51) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 18.3x - 46.8x 32.6x
Forward P/E multiples 14.7x - 44.3x 29.5x
Fair Price (1.87) - (4.51) (3.16)
Upside -194.7% - -329.2% -260.6%
1.97 USD
Stock Price
(3.16) USD
Fair Price

ICAD Relative Valuation - Historical P/E Data

Date P/E
2024-11-20 -15.10
2024-11-19 -15.29
2024-11-18 -14.90
2024-11-15 -16.08
2024-11-14 -17.50
2024-11-13 -22.94
2024-11-12 -23.53
2024-11-11 -20.69
2024-11-08 -20.88
2024-11-07 -18.53
2024-11-06 -18.24
2024-11-05 -17.55
2024-11-04 -17.06
2024-11-01 -17.84
2024-10-31 -18.24
2024-10-30 -18.14
2024-10-29 -18.63
2024-10-28 -18.92
2024-10-25 -19.22
2024-10-24 -18.33
2024-10-23 -17.16
2024-10-22 -17.26
2024-10-21 -17.84
2024-10-18 -18.53
2024-10-17 -19.12
2024-10-16 -19.12
2024-10-15 -15.59
2024-10-14 -15.00
2024-10-11 -14.31
2024-10-10 -13.63
2024-10-09 -14.22
2024-10-08 -14.95
2024-10-07 -15.29
2024-10-04 -15.29
2024-10-03 -15.00
2024-10-02 -15.78
2024-10-01 -15.00
2024-09-30 -15.34
2024-09-27 -16.27
2024-09-26 -15.83
2024-09-25 -15.20
2024-09-24 -15.25
2024-09-23 -15.39
2024-09-20 -15.49
2024-09-19 -15.29
2024-09-18 -15.98
2024-09-17 -16.18
2024-09-16 -15.78
2024-09-13 -16.08
2024-09-12 -14.90